Clinical Trial Update: EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trials update notes ongoing Phase 1/2 studies of EIK1005, a Werner helicase inhibitor, as monotherapy and in combination with pembrolizumab in adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Endometrial Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Microsatellite Instability-high Cancer
• Mismatch Repair-deficient Solid Tumors
• Solid Tumors

Drugs mentioned

• EIK1005
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Eikon Therapeutics | Conditions: Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING